BlueOcean NutraSciences Inc.
TSX VENTURE : BOC

BlueOcean NutraSciences Inc.

October 08, 2014 16:45 ET

BlueOcean NutraSciences Inc. Announces Issuance of Shares and Options

TORONTO, ONTARIO--(Marketwired - Oct. 8, 2014) - As announced in a press release dated August 5, 2014, Gavin Bogle was appointed interim CEO of BlueOcean NutraSciences Inc. ("BlueOcean" or the "Company") (TSX VENTURE:BOC), and agreed to receive a portion of his monthly fee in Common Shares.

The TSXV has approved the issuance and the Company has issued 26,315 Common Shares representing $2,500 of Gavin's August Fee, at a deemed price of $0.095 per Share. The Shares issued are subject to a four month plus one day hold period.

After the issuance of the Shares for the September Fee, the Company will have 50,717,693 Common Shares issued and outstanding.

In relation to Gavin Bogle accepting the appointment as CEO of the Company effective October 1, 2014, as announced in a press release dated September 16, 2014, 1,200,000 options were issued to Gavin at an exercise price of $0.20, vesting over the next twelve months.

About BlueOcean NutraSciences

BlueOcean is a Canadian company that develops specialty oils using innovative product platforms targeted at the rapidly growing health and Wellness and Animal Feed markets.

BlueOcean is developing three specialty oil products: AstaShrimp, AlgaOmega and AstaTene. BlueOcean owns 50% of the participating and voting rights in 70717 Newfoundland and Labrador Ltd, a joint venture with a major Atlantic Canada shrimp processor that provides the shrimp feedstock for the extraction of AstaShrimp, and 50% of Asta NutraSciences Inc., a company formed to develop natural astaxanthin based health and wellness products for the nutraceutical and animal feed markets. BlueOcean wholly owns its AlgaOmega product line.

Forward Looking Statements

This news release may contain forward-looking statements that are based on BlueOcean's expectations, estimates and projections regarding its business and the economic environment in which it operates. These statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements and readers should not place undue reliance on such statements. Statements speak only as of the date on which they are made, and the Company undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances, unless otherwise required to do so by law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Contact Information

  • BlueOcean NutraSciences Inc.
    Gavin Bogle
    CEO
    416-970-3266

    BlueOcean NutraSciences Inc.
    Dil Vashi
    Manager Corporate Development
    416-859-0909
    www.blueoceannutra.ca